Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma
-
Insignia Capital Group Announces Strategic Investment in Trooh Media
-
Form 8.3 - [IDOX PLC - 06 01 2026] - (CGWL)
-
Form 8.3 - [IQE PLC - 06 01 2026] - (CGAML)
-
Form 8.3 - [IDOX PLC - 06 01 2026] - (CGAML)
-
Oroco Announces Bought Deal Financing Led by Canaccord Genuity
-
ReconAfrica Announces C$20 Million Overnight Marketed Offering to Advance Multi-Zone Production Testing at Kavango West 1X, Accelerate Follow-on Appraisal Drilling on Kavango Discovery and Advance Act
-
Capitan Silver Completes C$6 Million Investment from Schroders
-
Form 8.3 - [IQE PLC - 05 01 2026] - (CGAML)
-
Canaccord Genuity Reiterates Hold Rating on Helen of Troy (HELE)
-
GH Research PLC (GHRS) PT Raised to $39 at Canaccord Genuity
-
Adicet Bio Inc. (ACET) PT Lowered to $18 at Canaccord Genuity
-
Eco (Atlantic) Oil and Gas Ltd. Announces Executives and Broker Appointment
-
Canaccord Genuity Downgrades Minto Apartment REIT (MI-U:CN) to Hold
-
Form 8.3 - [IDOX PLC - 02 01 2026] - (CGWL)
-
Form 8.3 - [IQE PLC - 02 01 2026] - (CGAML)
-
Stoke Therapeutics (STOK) PT Raised to $36 at Canaccord Genuity
-
Westport Announces Board of Directors Update
-
Canaccord Genuity Reiterates Buy Rating on Rivian Automotive Inc (RIVN), 'The US lacks any true EV alternative to Tesla'
-
Form 8.3 - [IQE PLC - 31 12 2025] - (CGAML)
-
Corcept Therapeutics (CORT) PT Lowered to $99 at Canaccord Genuity
-
Bioceres Crop Solutions (BIOX) PT Lowered to $2 at Canaccord Genuity
-
Form 8.3 - [IQE PLC - 30 12 2025] - (CGAML)
-
Total Voting Rights
-
LaFleur Minerals Closes Upsized, Fully Subscribed LIFE Offering and FT Offering
-
Western Gold Completes $2.74 Million Private Placement
-
Form 8.3 - [IQE PLC - 29 12 2025] - (CGAML)
-
Net Asset Value(s)
-
Canaccord Genuity Reiterates Buy Rating on TalkSpace (TALK)
-
Empire Metals Limited Announces Conditional Sale of 75% of Eclipse Gold Project
-
Form 8.3 - [IQE PLC - 24 12 2025] - (CGAML)
-
Condor Announces Closing of $13.65 Million Brokered Financing to Accelerate the 12 Well Drilling Program in Uzbekistan
-
Form 8.3 - [IDOX PLC - 23 12 2025] - (CGWL)
-
Form 8.3 - [IQE PLC - 23 12 2025] - (CGAML)
-
Motive Files Registration Statement for Proposed Initial Public Offering
-
Net Asset Value(s)
-
Canaccord Genuity Reiterates Buy Rating on Holley (HLLY)
-
Form 8.3 - [IQE PLC - 22 12 2025] - (CGAML)
-
Form 8.3 - [IDOX PLC - 22 12 2025] - (CGWL)
-
Closing of Strategic Acquisitions, Total Voting Rights, and Notification of Transactions of Persons Discharging Managerial Responsibilities
-
Tesla (TSLA) PT Raised to $551 at Canaccord Genuity
-
Ninepoint Partners Announces Ninepoint 2026 Flow-Through Limited Partnership
-
Sharon AI Completes US$100m Convertible Note Capital Raising
-
Northern Graphite raises $1.35 million in private placement
-
Northern Graphite Completes $1.35 Million Non-Brokered Private Placement
-
NeuroOne Medical appoints Jason Mills to board of directors
-
NeuroOne(R) Appoints Jason Mills to the Board of Directors
-
Lithium Royalty Corp. Agrees to Be Acquired by Altius Minerals Corporation
-
NeuroOne® Appoints Jason Mills to the Board of Directors
-
Form 8.3 - [JTC PLC - 19 12 2025] - (CGAML)
